قائمة أكبر شركات الطب الحيوي حسب الدخل

عودة للموسوعة

قائمة أكبر شركات الطب الحيوي حسب الدخل

القائمة التالية لأكبر شركات الأدوية، التكنولوجيا الحيوية والطب المستقلة مرتبة حسب الدخل (10 بليون دولار) تبعاً للسنة المالية، ولا تتضمن شركات التكنولوجيا الحيوية المملوكة أوالتي تعتبر جزء مجموعات الأدوية الكبرى.


أكبر شركات الأدوية العالمية بدخل أكبر منعشرة بليون

ترتيب شعار الشركة 2019
بليون$
2018
بليون$
2017
بليون$
2016
بليون$
2015
بليون$
2014
بليون$
2013
بليون$
2012
بليون$
2011
بليون$
1 جونسون أند جونسون
NYSE: JNJ
82.06 81.60 76.50 71.89 70.10 74.30 71.31 67.20 65.00
2 روش
SIX: ROG
63.85 56.86 57.37 50.11 47.70 49.86 48.53 47.80 45.21
3 فايزر
NYSE: PFE
51.75 53.60 52.54 52.82 48.85 49.61 51.58 58.99 65.26
4 نوڤارتس
NYSE: NVS
47.45 44.75 49.11 48.52 49.41 58.00 57.36 56.67 58.57
5 4 باير
FWB: BAYN
38.24 Q3 45.06 37.94 25.27 24.09 25.47 24.17 24.30 23.11
6 گلاكسوسميث كلاين
LSE: GSK
32.22 Q3 43.14 42.05 34.79 29.84 37.96 41.61 39.93 41.39
7 مرك
NYSE: MRK
34.98 Q3 42.30 40.10 39.80 39.50 42.24 44.03 47.27 48.05
8 Decrease 3 سانوفي
NYSE: SNY
29.57 Q3 39.07 42.91 36.57 36.73 43.07 42.08 46.41 44.34
9 1 آب‌ڤي
NYSE: ABBV
24.56 Q3 32.75 28.22 25.56 22.82 19.96 18.79
10 معامل أبوت
NASDAQ: ABT
31.90 30.60 27.39 20.85 20.41 20.25 21.85 39.87 38.85
11 ثرموفيشر ساينتفيك
NYSE: TMO
25.54 24.36 20.92 18.27 16.97 16.89 13.09 12.51 11.56
11 1 إلاي لـِلي
NYSE: LLY
22.32 21.49 22.90 21.22 20.00 19.62 23.11 22.60 24.29
12 1 أمجين
NASDAQ: AMGN
23.40 23.70 22.80 22.99 21.66 20.06 18.68 17.30 15.58
13 4 بريستول-مايرز سكويب
NASDAQ: BMY
18.32 Q3 22.56 20.80 19.43 16.56 15.88 16.39 17.62 21.24
14 Decrease 3 گلعاد للعلوم
NASDAQ: GILD
16.32 Q3 22.13 25.70 30.39 32.15 24.47 10.80 9.70 8.39
15 Decrease 1 أسترازنكا
LSE: AZN
17.72 Q3 22.09 22.47 23.00 24.71 26.10 25.71 27.97 33.59
16 Decrease 1 / تـِڤا للصناعات الدوائية
NASDAQ: TEVA
4.30 Q1 18.90 22.40 21.90 20.00 20.27 20.31 18.31 16.12
17 بورنگر إنگل‌هايم
خاصة
19.48 21.67 17.54 16.41 17.70 18.68 18.89 18.34
18 تاكيدا للأدوية
TYO: 4502
19.10 16.70 15.96 14.93 16.84 17.36 18.91 17.80
19 مجموعة مرك
ETR: MRK
8.66 Q2 16.48 18.70 16.62 14.25 15.29 14.73 14.36 14.31
20 نوڤونورديسك
NYSE: NVO
13.39 Q3 16.99 18.77 16.61 16.06 15.83 14.88 13.48 11.56
21 ألرگان
NYSE: AGN
7.69 Q2 15.78 15.94 14.57 15.07 12.88 8.68 5.91 4.58
22 داناهر كورپوريشن
NYSE: DHR
15.07 Q3 19.89 18.33 16.88 20.56 19.91 19.12 18.26 16.09
23 سلجين
NASDAQ: CELG
12.95 Q3 15.28 13.00 11.23 9.26 7.67 6.49 5.51 4.84
24 بيوجين
NASDAQ: BIIB
10.71 Q3 13.45 12.30 11.40 10.80 9.70 6.90 5.50 5.00
25 أستلاس فارما
TYO: 4503
12.27 12.07 12.63 11.48 10.49 9.25 8.92 8.78
26 لاب‌كورپ
NYSE: LH
8.60 Q3 11.33 10.31 9.55 8.51 6.01 5.81 5.67 5.54
27 باكستر إنترناشونال
NYSE: BAX
8.28 Q3 11.13 10.56 10.16 9.97 10.72 14.97 14.19 13.89
28 ماي‌لان
NASDAQ: MYL
5.35 Q2 11.43 11.91 11.08 9.43 7.72 6.91 6.80 6.13


انظر أيضاً

  • قائمة أكبر شركات الأدوية والتكنولوجيا الحيوية

الهوامش

  1. ^ Includes the consolidated results of Shire plc from Q4 2018

المصادر

  1. ^ https://www.biospace.com/article/releases/johnson-and-amp-johnson-reports-2019-fourth-quarter-and-full-year-results-/?s=72
  2. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results:". Content Lab - U.S.
  3. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  4. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  5. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results:".
  6. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  7. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  8. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:".
  9. ^ "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:".
  10. ^ https://www.roche.com/dam/jcr:e49f6995-e813-43c1-9302-c9b7d0bddbc8/en/irp200130-a.pdf
  11. ^ https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf
  12. ^ "Roche reports good results in 2017". www.roche.com.
  13. ^ https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
  14. ^ https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
  15. ^ https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
  16. ^ https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
  17. ^ https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
  18. ^ https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
  19. ^ https://www.biospace.com/article/releases/pfizer-reports-fourth-quarter-and-full-year-2019-results/?s=72
  20. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf
  21. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
  22. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
  23. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
  24. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
  25. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
  26. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
  27. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
  28. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf
  29. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
  30. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2017-en.pdf
  31. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
  32. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
  33. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
  34. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
  35. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
  36. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
  37. ^ https://www.bayer.com/en/quarterly-reports.aspx
  38. ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
  39. ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
  40. ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
  41. ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
  42. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  43. ^ https://www.bayer.com/en/ar-2013.pdfx
  44. ^ https://www.bayer.com/en/ar-2012.pdfx
  45. ^ https://www.bayer.com/en/ar-2011.pdfx
  46. ^ https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-sales-of-94-billion-plus16-aer-plus11-cer-pro-forma-plus6-cerstar/
  47. ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  48. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
  49. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf
  50. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
  51. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
  52. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
  53. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf
  54. ^ https://www.gsk.com/media/2696/annual-report-2011.pdf
  55. ^ https://www.biospace.com/article/releases/merck-announces-third-quarter-2019-financial-results/?s=72
  56. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  57. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
  58. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
  59. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
  60. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
  61. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
  62. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
  63. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
  64. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/Q3_2019_Results_Press_Release_EN.pdf?la=en&hash=8BF184008D241B7AB03515AE9F73CEB3
  65. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
  66. ^ https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
  67. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf
  68. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
  69. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
  70. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
  71. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
  72. ^ https://en.sanofi.com/Images/29804_20F_2011.pdf
  73. ^ https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-third-quarter-2019-financial-results
  74. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  75. ^ "Financial Release - AbbVie". investors.abbvie.com.
  76. ^ "Financial Release - AbbVie". investors.abbvie.com.
  77. ^ "Financial Release - AbbVie". investors.abbvie.com.
  78. ^ "Financial Release - AbbVie". investors.abbvie.com.
  79. ^ "Financial Release - AbbVie". investors.abbvie.com.
  80. ^ https://www.biospace.com/article/releases/abbott-reports-fourth-quarter-2019-results-announces-strong-forecast-for-2020/?s=72
  81. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  82. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  83. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  84. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  85. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  86. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  87. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  88. ^ "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
  89. ^ https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
  90. ^ https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
  91. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx
  92. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx
  93. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx
  94. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
  95. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
  96. ^ http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
  97. ^ http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
  98. ^ https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
  99. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  100. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
  101. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  102. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
  103. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
  104. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  105. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  106. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
  107. ^ https://www.biospace.com/article/releases/amgen-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
  108. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  109. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  110. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  111. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  112. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  113. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  114. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  115. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  116. ^ https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2019/q3/Q32019-Earnings-Release.pdf
  117. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  118. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  119. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  120. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  121. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  122. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  123. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
  124. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
  125. ^ https://www.biospace.com/article/releases/gilead-sciences-announces-third-quarter-2019-financial-results/?s=72
  126. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  127. ^ "Investor Overview". Gilead Sciences.
  128. ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/q3/Year-to-date_and_Q3_2019_Results_announcement.pdf
  129. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
  130. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
  131. ^ https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
  132. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  133. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  134. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  135. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  136. ^ "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
  137. ^ https://s22.q4cdn.com/366566841/files/doc_financials/2019/quarterly/Q1-2019-PR-tables.pdf
  138. ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf
  139. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results".
  140. ^ http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
  141. ^ http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
  142. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  143. ^ http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
  144. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  145. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  146. ^ http://annualreport.boehringer-ingelheim.com/fileadmin/Download-Center/BI_GB_18_en_ohne_Unterschriften.pdf
  147. ^ "Boehringer Ingelheim 2017 Annual Report" (PDF). www.boehringer-ingelheim.com.
  148. ^ "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  149. ^ https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/
  150. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  151. ^ https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2019-q2/en/2019-Q2-Press-Release-EN.pdf
  152. ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
  153. ^ "404 page - EMD Group". www.emdgroup.com.
  154. ^ http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
  155. ^ http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
  156. ^ http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
  157. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20191101_Financial%20statement%20Q3%202019.pdf
  158. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf
  159. ^ "News details". www.novonordisk.com.
  160. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
  161. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  162. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  163. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  164. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  165. ^ http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
  166. ^ https://www.allergan.com/investors/quarterly-results
  167. ^ "Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results". BioSpace.
  168. ^ https://www.allergan.com/news/news/thomson-reuters/allergan-reports-solid-finish-to-2017
  169. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTczMDc2fENoaWxkSUQ9Mjc1MzEzfFR5cGU9MQ==&t=1
  170. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM5MDk2fENoaWxkSUQ9MjI4NjI0fFR5cGU9MQ==&t=1
  171. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTc3MTM2fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  172. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDYwMzczfENoaWxkSUQ9NDg4Mzk1fFR5cGU9MQ==&t=1
  173. ^ https://www.biospace.com/article/releases/danaher-reports-third-quarter-2019-results/?s=72
  174. ^ http://investors.danaher.com/download/Danaher_Annual_Report_2018.pdf
  175. ^ http://investors.danaher.com/download/danaher_2017_annualreport.pdf
  176. ^ http://investors.danaher.com/download/Danaher_2016+Annual+Report.pdf
  177. ^ http://investors.danaher.com/download/2015+Danaher+Annual+Report.pdf
  178. ^ http://investors.danaher.com/download/DHR_AR_2014.pdf
  179. ^ http://investors.danaher.com/download/DHR_AR_2013.pdf
  180. ^ http://investors.danaher.com/download/DHR_AR_2012.pdf
  181. ^ http://investors.danaher.com/download/DHR_AR_2011.pdf
  182. ^ https://s22.q4cdn.com/728481125/files/doc_financials/2019/q3/2019-10-31-Q3-2019-earnings-deck_FINAL.pdf
  183. ^ "Celgene Reports Fourth Quarter and Full Year 2018 Operating and Financial Results". BioSpace.
  184. ^ https://investors.biogen.com/static-files/7863b554-d325-44e8-9c2d-ceace9698781
  185. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
  186. ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
  187. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
  188. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
  189. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
  190. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
  191. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
  192. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf
  193. ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
  194. ^ https://www.biospace.com/article/releases/labcorp-announces-2019-third-quarter-results-and-updates-2019-guidance/?s=72
  195. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE2OTE0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636873221632383468
  196. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjI4ODI1fENoaWxkSUQ9LTF8VHlwZT0z&t=1
  197. ^ https://s22.q4cdn.com/911189824/files/doc_presentations/2019/10/Q3-2019-BAX-PRELIMINARY-RESULTS-FINANCIAL-SCHEDULES-(FINAL).pdf
  198. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  199. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  200. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
  201. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
  202. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf
  203. ^ https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf
  204. ^ https://www.biospace.com/article/releases/mylan-reports-second-quarter-2019-results/?s=72
  205. ^ http://investor.mylan.com/static-files/ed066de0-8491-4327-a044-9bb136d5b8c3
  206. ^ http://investor.mylan.com/static-files/29cc2678-5735-461a-9972-6ac01dfce6c4

وصلالات خارجية

نطقب:Biotechnology

تاريخ النشر: 2020-06-08 22:42:41
التصنيفات: شركات مدرجة في بورصة نيويورك, شركات مدرجة في بورصة فرانكفورت, Companies listed on NASDAQ, شركات تكنولوجيا حيوية, قوائم شركات الأدوية

مقالات أخرى من الموسوعة

سحابة الكلمات المفتاحية، مما يبحث عنه الزوار في كشاف:

آخر الأخبار حول العالم

خبير: مصير ساكاشفيلي ينتظر زيلينسكي

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:38
مستوى الصحة: 90% الأهمية: 94%

لا مفر من الحرب: الصين وجدت طريقة للتغلب على أمريكا في تايوان

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:38
مستوى الصحة: 85% الأهمية: 96%

حملة تركية لمساعدة أهالي غزة

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:30
مستوى الصحة: 76% الأهمية: 94%

"أسواق العثيم" تبيع أرضا في المدينة المنورة بـ 211.3 مليون ريال

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:17:36
مستوى الصحة: 89% الأهمية: 93%

الأمم المتحدة توجه رسالة لـ"نصر الله"

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:31
مستوى الصحة: 89% الأهمية: 87%

دبلوماسي أمريكي يشكو من "أصدقاء" بوتين في الناتو

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:31
مستوى الصحة: 86% الأهمية: 86%

اقتحام منزل ترمب.. هل تمنعه من الترشح أم تضر بايدن؟

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:17:09
مستوى الصحة: 84% الأهمية: 100%

مرتضى منصور يكشف عن مكافأة خيالية للاعبي الزمالك

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:35
مستوى الصحة: 90% الأهمية: 94%

إنتاجية العامل الأميركي تهبط بشدة في الربع الثاني

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:17:33
مستوى الصحة: 81% الأهمية: 86%

سيارته فضحته.. اعتقال المتهم بقتل 4 مسلمين في أميركا

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:17:10
مستوى الصحة: 77% الأهمية: 85%

مصادر: بيانات معهد البترول تظهر ارتفاع مخزونات النفط الأميركية 

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:17:29
مستوى الصحة: 81% الأهمية: 87%

90 دقيقة تأخير في حركة القطارات على خط «القاهرة - الإسكندرية».. 10 أغسطس

المصدر: بوابة أخبار اليوم - مصر التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:18:11
مستوى الصحة: 45% الأهمية: 53%

الحكومة اليابانية تقدم استقالتها بشكل كامل

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:32
مستوى الصحة: 94% الأهمية: 91%

أرباح "غازكو" تتراجع 12.9% إلى 31.8 مليون ريال في الربع الثاني

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:17:26
مستوى الصحة: 76% الأهمية: 87%

البحث عن امرأة هاربة.. تفتيش قصر رئيس بيرو

المصدر: العربية - السعودية التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:47
مستوى الصحة: 80% الأهمية: 95%

سلطات منطقة زابوروجيه: كييف تتعمد قصف المحطة النووية

المصدر: RT Arabic - روسيا التصنيف: سياسة
تاريخ الخبر: 2022-08-10 09:16:33
مستوى الصحة: 91% الأهمية: 94%

تحميل تطبيق المنصة العربية